Introducing Hans Boerma and Phil Bromley: Pioneering Healthcare Innovation at Kneu Health

With over three decades of corporate strategy experience, Hans Boerma brings invaluable insights to our team. He has a proven track record in forming strategic alliances for Health Information Technology (HIT) companies, spanning from Fortune 500 firms to nimble startups. Hans's expertise lies in driving growth in provider and payer-focused technologies, backed by his innovative approach to healthcare solutions. His keen focus on analytics, care management, mobile solutions, and digital health positions him perfectly to play a pivotal role in shaping our company's trajectory towards unparalleled success.

Phil Bromley, our new Head of Regulatory, brings over twenty years of experience to Kneu Health. His tenure as the VP of Quality & Regulatory at Current Health speaks volumes about his prowess in navigating complex regulatory landscapes. Phil has been instrumental in achieving numerous regulatory clearances and ensuring compliance with ISO standards, HIPAA, and GDPR regulations. His expertise in regulatory strategy development, technical documentation, product development, and risk management will be invaluable assets as we navigate the intricate regulatory framework governing healthcare technologies.

Driving Innovation and Compliance

Together, Hans and Phil will lead us in driving innovation while maintaining the highest regulatory standards. Their combined expertise will serve as a guiding beacon as we continue to pioneer advancements in healthcare technology – making Parkinson's and Dementia care accessible for all.

About Kneu Health

Kneu Health is pioneering a new model of precision neurology for Parkinson's and dementia: care that is proactive, compassionate, and designed for the realities of everyday life. Built on one of the most advanced longitudinal datasets in Parkinson's care — the Oxford Parkinson's Disease Centre Discovery Cohort — Kneu's smartphone-based platform turns structured at-home assessments into actionable insights, enabling clinicians to detect decline earlier and act before symptoms escalate. The technology analyzes speech, movement, memory, and cognition in just minutes a day, using trained models to generate predictive scores and digital biomarkers that inform treatment and care. Kneu is working with leading U.S. health systems to expand access, ease workforce strain, and set a new standard for brain health monitoring.